Skip to main content Accessibility help
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Adjuvant treatments for recurrent respiratory papillomatosis: a descriptive review and proposed management guideline in adults

  • Edward Balai, Emilie AC Dronkers, Chadwan A Yaghchi, Dorothy Gujral, Guri Sandhu, Aphrodite Iacovidou
  • Journal:
    The Journal of Laryngology & Otology / Volume 138 / Issue 12 / December 2024
    Published online by Cambridge University Press:
    21 October 2024, pp. 1133-1143
    Print publication:
    December 2024
  • Objective

    Recurrent respiratory papillomatosis is a rare disease characterised by growth of papilloma within the respiratory tract. The disease course is variable but can require frequent surgical interventions alongside adjuvant medical treatments. There is no definitive curative treatment or gold-standard guidelines for management. We aimed to evaluate current and potential future adjuvant treatments and propose a management guideline for adult patients.

    Methods

    Relevant articles were identified through searching databases, reference lists and grey literature.

    Results

    Systemic bevacizumab appears to be the most effective adjuvant treatment currently available. However, intralesional cidofovir also achieves a high complete-response rate in adults and the Gardasil vaccine demonstrates preventative and therapeutic value. The INO-3107 DNA vaccine is a promising potential future adjuvant treatment.

    Conclusions

    This review provides a detailed examination of current and potential future adjuvant treatments. Based on the literature, we have developed a management guideline for adult patients with recurrent respiratory papillomatosis.